secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001562762-22-000339
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q2 net sales $263.6M (+5% YoY); GAAP EPS $0.53, non-GAAP $0.56; Enabling Tech +41.7%
--------------------------------------------------------------------------------

- Net sales $263.6M, +5.0% as-reported and +6.5% constant currency vs Q2 2021.
- GAAP net income $54.6M (+31.4% YoY); diluted EPS $0.53 vs $0.40.
- Non-GAAP diluted EPS $0.56; adjusted EBITDA $91.9M (34.9% of sales).
- Enabling Technologies sales $29.4M (+41.7%) driven by robotics and Excelsius 3D.
- Reaffirmed FY2022 guidance: net sales $1.025B, non-GAAP diluted EPS $2.10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000339/0001562762-22-000339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000339/gmed-20220804x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer